Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations

Ellis MS, Kasper ZA, Cicero TJ. Twin epidemics: the surging rise of methamphetamine use in chronic opioid users. Drug Alcohol Depend. 2018;193:14–20.

Article  PubMed  Google Scholar 

Strickland JC, Havens JR, Stoops WW. A nationally representative analysis of “twin epidemics”: rising rates of methamphetamine use among persons who use opioids. Drug Alcohol Depend. 2019;204:107592.

Article  PubMed  PubMed Central  Google Scholar 

Goodwin RD, Moeller SJ, Zhu J, Yarden J, Ganzhorn S, Williams JM. The potential role of cocaine and heroin co-use in the opioid epidemic in the United States. Addict Behav. 2021;113:106680.

Article  PubMed  Google Scholar 

Ahmad FB, Rossen LM, Sutton P. Provisional drug overdose death counts, for 12 months ending November 2021, updated April, 2022. National Center for Health Statistics; 2022. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.

Gladden RM, O’Donnell J, Mattson CL, Seth P. Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine—25 states, July–December 2017 to January–June 2018. MMWR Morb Mortal Wkly Rep. 2019;68(34):737–44.

Article  PubMed  PubMed Central  Google Scholar 

Shover CL, Falasinnu TO, Dwyer CL, Santos NB, Cunningham NJ, Freedman RB, et al. Steep increases in fentanyl-related mortality west of the Mississippi river: recent evidence from county and state surveillance. Drug Alcohol Depend. 2020;216:108314.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kerr T, Fairbairn N, Tyndall M, Marsh D, Li K, Montaner J, et al. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007;87(1):39–45.

Article  PubMed  Google Scholar 

Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, et al. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2):e1920622.

Article  PubMed  Google Scholar 

Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550.

Article  PubMed  PubMed Central  Google Scholar 

Lee JD, Nunes EV Jr, Novo P, Bachrach K, Bailey GL, Bhatt S, et al. Comparative effectiveness of extended-release naltrexone versus buprenorphine–naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. Lancet. 2018;391(10118):309–18.

Article  CAS  PubMed  Google Scholar 

Xu KY, Mintz CM, Presnall N, Bierut LJ, Grucza RA. Comparative effectiveness associated with buprenorphine and naltrexone in opioid use disorder and cooccurring polysubstance use. JAMA Netw Open. 2022;5(5):e2211363.

Article  PubMed  PubMed Central  Google Scholar 

Ford BR, Bart G, Grahan B, Shearer RD, Winkelman TNA. Associations between polysubstance use patterns and receipt of medications for opioid use disorder among adults in treatment for opioid use disorder. J Addict Med. 2021;15(2):159–62.

Article  CAS  PubMed  Google Scholar 

Frost MC, Lampert H, Tsui JI, Iles-Shih MD, Williams EC. The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review. Addict Sci Clin Pract. 2021;16(1):62.

Article  PubMed  PubMed Central  Google Scholar 

Cunningham CO, Giovanniello A, Kunins HV, Roose RJ, Fox AD, Sohler NL. Buprenorphine treatment outcomes among opioid-dependent cocaine users and non-users. Am J Addict. 2013;22(4):352–7.

Article  PubMed  PubMed Central  Google Scholar 

Bunting AM, Krawczyk N, Choo TH, Pavlicova M, McNeely J, Tofighi B, et al. Polysubstance use before and during treatment with medication for opioid use disorder: prevalence and association with treatment outcomes. J Subst Abuse Treat. 2022;143:108830.

Article  CAS  PubMed  Google Scholar 

Rowe CL, Santos GM, Kornbluh W, Bhardwaj S, Faul M, Coffin PO. Using ICD-10-CM codes to detect illicit substance use: a comparison with retrospective self-report. Drug Alcohol Depend. 2021;221:108537.

Article  CAS  PubMed  Google Scholar 

Jones CM, Underwood N, Compton WM. Increases in methamphetamine use among heroin treatment admissions in the United States, 2008–17. Addiction. 2020;115(2):347–53.

Article  PubMed  Google Scholar 

Chan B, Freeman M, Ayers C, Korthuis PT, Paynter R, Kondo K, et al. A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders. Drug Alcohol Depend. 2020;216:108193.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kennedy-Martin T, Curtis S, Faries D, Robinson S, Johnston J. A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials. 2015;16:495.

Article  PubMed  PubMed Central  Google Scholar 

Susukida R, Crum RM, Stuart EA, Ebnesajjad C, Mojtabai R. Assessing sample representativeness in randomized controlled trials: application to the National Institute of drug abuse clinical trials network. Addiction. 2016;111(7):1226–34.

Article  PubMed  PubMed Central  Google Scholar 

Humphreys K, Weisner C. Use of exclusion criteria in selecting research subjects and its effect on the generalizability of alcohol treatment outcome studies. Am J Psychiatry. 2000;157(4):588–94.

Article  CAS  PubMed  Google Scholar 

Humphreys K, Weingardt KR, Harris AH. Influence of subject eligibility criteria on compliance with national institutes of health guidelines for inclusion of women, minorities, and children in treatment research. Alcohol Clin Exp Res. 2007;31(6):988–95.

Article  PubMed  Google Scholar 

Storbjork J, Garfield JB, Larner A. Implications of eligibility criteria on the generalizability of alcohol and drug treatment outcome research: a study of real-world treatment seekers in Sweden and in Australia. Subst Use Misuse. 2017;52(4):439–50.

Article  PubMed  Google Scholar 

Kelpin SS, Ondersma SJ, Weaver M, Svikis DS. Representativeness of patients enrolled in a primary care clinical trial for heavy/problem substance use. Subst Abus. 2018;39(4):469–75.

Article  PubMed  PubMed Central  Google Scholar 

Blanco C, Olfson M, Okuda M, Nunes EV, Liu SM, Hasin DS. Generalizability of clinical trials for alcohol dependence to community samples. Drug Alcohol Depend. 2008;98(1–2):123–8.

Article  PubMed  PubMed Central  Google Scholar 

Okuda M, Hasin DS, Olfson M, Khan SS, Nunes EV, Montoya I, et al. Generalizability of clinical trials for cannabis dependence to community samples. Drug Alcohol Depend. 2010;111(1–2):177–81.

Article  PubMed  PubMed Central  Google Scholar 

Lister JJ, Weaver A, Ellis JD, Himle JA, Ledgerwood DM. A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States. Am J Drug Alcohol Abuse. 2020;46(3):273–88.

Article  PubMed  Google Scholar 

Seidler E, Keshaviah A, Brown CL, Wood E, Granick L, Kimball A. Geographic distribution of clinical trials may lead to inequities in access. Clin Invest. 2014;4:373–80.

Article  CAS  Google Scholar 

McCabe SE, West BT, Jutkiewicz EM, Boyd CJ. Multiple DSM-5 substance use disorders: a national study of US adults. Hum Psychopharmacol. 2017;32(5):e2625.

Article  Google Scholar 

Kim HS, Kim JH. Proceed with caution when using real world data and real world evidence. J Korean Med Sci. 2019;34(4):e28.

Article  PubMed  PubMed Central  Google Scholar 

Bareinboim E, Pearl J. Causal inference and the data-fusion problem. Proc Natl Acad Sci. 2016;113(27):7345–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pearl J, Bareinboim E. Transportability across studies: a formal approach. California: University of Los Angeles; 2011.

Book  Google Scholar 

Pearl J, Bareinboim E. External validity: from Do-Calculus to transportability across populations. Stat Sci. 2014;29(4):579–95.

Article  Google Scholar 

Korthuis PT, Cook RR, Lum PJ, Waddell EN, Tookes H, Vergara-Rodriguez P, et al. HIV clinic-based extended-release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non-blinded, randomized non-inferiority trial. Addiction. 2022;117(7):1961–71.

Article  PubMed  PubMed Central  Google Scholar 

National Center for Health Statistics. Data hosting: national survey on drug use and health. https://www.cdc.gov/rdc/b1datatype/nsduh.htm.

The Substance Use and Mental Health Services Administration. Treatment episode dataset: admissions. https://www.datafiles.samhsa.gov/study-series/treatment-episode-data-set-admissions-teds-nid13518.

Jenkins RA, Whitney BM, Nance RM, Allen TM, Cooper HLF, Feinberg J, et al. The rural opioid initiative consortium description: providing evidence to understand the fourth wave of the opioid crisis. Addict Sci Clin Pract. 2022;17(1):38.

Article  PubMed  PubMed Central  Google Scholar 

Vandevenne M, Vandenbussche H, Verstraete A. Detection time of drugs of abuse in urine. Acta Clin Belg. 2000;55(6):323–33.

Article  CAS  PubMed  Google Scholar 

Azur MJ, Stuart EA, Frangakis C, Leaf PJ. Multiple imputation by chained equations: what is it and how does it work? Int J Methods Psychiatr Res. 2011;20(1):40–9.

Article  PubMed  PubMed Central 

留言 (0)

沒有登入
gif